Lipe & Dalton’s Freeport-McMoran FCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,000
Closed -$170K 108
2023
Q4
$170K Buy
+4,000
New +$148K 0.09% 80
2015
Q3
Sell
-148,170
Closed -$2.76M 66
2015
Q2
$2.76M Sell
148,170
-4,695
-3% -$96.9K 1.98% 26
2015
Q1
$2.9M Sell
152,865
-130
-0.1% -$2.57K 2% 28
2014
Q4
$3.57M Sell
152,995
-2,855
-2% -$78.8K 2.39% 24
2014
Q3
$5.09M Buy
155,850
+365
+0.2% +$13.3K 3.33% 11
2014
Q2
$5.67M Buy
155,485
+3,690
+2% +$126K 3.57% 7
2014
Q1
$5.14M Buy
151,795
+5,569
+4% +$185K 3.44% 8
2013
Q4
$5.52M Buy
146,226
+5,386
+4% +$191K 3.77% 5
2013
Q3
$4.66M Buy
140,840
+39,235
+39% +$1.2M 3.42% 11
2013
Q2
$2.81M Buy
+101,605
New +$3.1M 2.33% 24

Other funds holding FCX

Lipe & Dalton's FCX Position: Q1 2024 in Review

Lipe & Dalton sold out of Freeport-McMoran (FCX) in Q1 2024, closing a stake of 4,000 shares — an estimated $170K sold.

Lipe & Dalton first reported a position in FCX in Q2 2013 and held it in 10 quarters. The position peaked at $5.67M in Q2 2014. 1,453 funds tracked by Wall St. Rank hold FCX as of Q1 2024.

  • Lipe & Dalton reported no remaining Freeport-McMoran position as of Q1 2024 after selling out during the quarter.
  • Lipe & Dalton sold 4,000 Freeport-McMoran shares in Q1 2024, an estimated $170K.
  • Lipe & Dalton first reported a position in Freeport-McMoran in Q2 2013 and held it in 10 quarters.
  • Lipe & Dalton's Freeport-McMoran position peaked at $5.67M in Q2 2014.
  • 1,453 funds tracked by Wall St. Rank held Freeport-McMoran as of Q1 2024.

Based on Lipe & Dalton's 13F filing for Q1 2024, filed 7 May 2024.